Article
Evaluation of methylenetetrahydrofolate reductase gene variant (C677T) as risk factor for bipolar disorder.
Cellular and molecular biology (Noisy-le-Grand, France) - 27 Sept 2011
Rai V
Abstract excerpt
Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in the metabolism of folate, whose role in bipolar disorder is controversial. The aim of the present study was to assess the risk of MTHFR C677T polymorphism for bipolar disorder. The author performed a meta-analysis and pooled data from individual case-control studies that examined the association between C677T polymorphism and bipolar disorder...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
